4basebio says "tier one" partner tests vaccine from its template
(Alliance News) - 4basebio PLC on Monday said its synthetic DNA product has been used in US clinical trials by a "global tier one" pharmaceutical partner. Read More
| Price | 590.00p on 12-01-2026 at 19:10:04 |
|---|---|
| Change | 0.00p 0% |
| Buy | 630.00p |
| Sell | 550.00p |
| Last Trade: | Sell 6.00 at 550.00p |
| Day's Volume: | 193 |
| Last Close: | 590.00p |
| Open: | 590.00p |
| ISIN: | GB00BMCLYF79 |
| Day's Range | 590.00p - 590.00p |
| 52wk Range: | 590.00p - 1,250.00p |
| Market Capitalisation: | £91.36m |
| VWAP: | 561.65596p |
| Shares in Issue: | 15.48m |
Sector: Medicine and Biotech
Listed In: FTSE AIM All-Share,
4basebio Plc (4BB) Latest Trades |
||||
| Buy/Sell | Volume | Trade Prc | Trade Type | Trade Time |
|---|---|---|---|---|
| Sell* | 6 | 550.00p | SI Trade |
13:13:56 - 12-Jan-26 |
| Sell* | 27 | 560.00p | Ordinary |
12:35:47 - 12-Jan-26 |
| Buy* | 8 | 607.45p | Ordinary |
08:20:35 - 12-Jan-26 |
| Sell* | 152 | 560.00p | Ordinary |
08:00:11 - 12-Jan-26 |
| Buy* | 470 | 602.00p | Ordinary |
14:37:06 - 09-Jan-26 |
| Buy* | 340 | 605.00p | Ordinary |
14:23:22 - 09-Jan-26 |
| Sell* | 1,000 | 560.00p | Ordinary |
14:14:39 - 09-Jan-26 |
| Buy* | 1 | 630.00p | SI Trade |
11:51:55 - 09-Jan-26 |
| Buy* | 32 | 607.45p | Ordinary |
11:38:46 - 09-Jan-26 |
| Buy* | 491 | 607.45p | Ordinary |
10:29:05 - 09-Jan-26 |
4basebio Plc (4BB) Regulatory News |
||
| Date | Source | Headline |
|---|---|---|
| 27th Oct 2025 7:00 am | PRN | Synthetic opDNA® utilised in Phase I/II US clinical trials |
| 10th Oct 2025 11:30 am | PRN | Result of Extraordinary General Meeting |
| 30th Sep 2025 4:20 pm | PRN | Director Dealing |
| 29th Sep 2025 7:00 am | PRN | Half-year Report |
| 22nd Jul 2025 7:00 am | PRN | Employee Long Term Incentive Plan and Issue of Equity |
| 8th Jul 2025 10:30 am | PRN | Director Appointment, Board Change |
| 3rd Jul 2025 7:00 am | PRN | Holding(s) in Company |
| 3rd Jul 2025 7:00 am | PRN | Holding(s) in Company |
| 2nd Jul 2025 7:00 am | PRN | Holding(s) in Company |
| 2nd Jul 2025 7:00 am | PRN | Holding(s) in Company |